Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US keen to work with Indian investigators in COVID-19 clinical trials: Dr Fauci
The partnerships between the NIH and India's DBT as well as the ICMR have helped produce important scientific and public health…
Sanofi partners with BIG, EORTC, AFT to study amcenestrant for ER+ breast cancer treatment
Amcenestrant is an oral SERD that antagonises and degrades the estrogen receptor (ER), resulting in inhibition of the ER signaling…
Countries, health partners deliberate on boosting response to COVID-19 in WHO South-East Asia Region
For five consecutive weeks, the Region reported rapid surge of COVID-19, registering over two million new cases
Glenmark gets US FDA approval for Theophylline ER Tablets, 300 mg and 450 mg
Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity on the 450 mg
Lupin launches generic version of Brovana in US
It is indicated for the long-term, twice-daily maintenance treatment of bronchoconstriction in patients with COPD
Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada
Similar to the US profit share arrangement, Ocugen will retain 45 per cent of the profits from sales of COVAXIN in Canada
Perspective on WTO IPR Waiver negotiations
Professor Prabuddha Ganguli, CEO, Vision-IPR emphasises that negotiations at the WTO need to be holistic, being mindful of the…
Diagnosed prevalent cases of systemic sclerosis in 7MM to reach 187,000 by 2030: GlobalData
The US will have the highest number of diagnosed prevalent cases of systemic sclerosis in the 7MM at 114,000
Organon launches as Women’s Health company
Anjan Sen will lead the operations for India and countries of South Asia region
Zydus Cadila gets tentative US FDA nod for Osimertinib Tablets
Osimertinib is a kinase inhibitor used to treat lung cancer